Andrew T. Tenaglia, BA

home / authors / andrew-t-tenaglia-ba

Articles

February 18th 2020

Concomitant Medical Conditions and Total Cost of Care in Patients With Migraine: A Real-World Claims Analysis

Michael Polson, PharmD, MS Ted D. Williams, PharmD, BCPS Lindsay C. Speicher, JD Mkaya Mwamburi, MD, PhD, MA Peter S. Staats, MD, MBA Andrew T. Tenaglia, BA

February 18th 2020

Real-World Assessment of Concomitant Opioid Utilization and Associated Trends in Patients With Migraine

Anne Kangethe, PharmD, PhD, RPh, MPH Michael Polson, PharmD, MS Themmi M. Evangelatos, PharmD, MSBA Lindsay C. Speicher, JD Andrew T. Tenaglia, BA Peter S. Staats, MD, MBA Eric J. Liebler Mkaya Mwamburi, MD, PhD, MA

December 13th 2018

Review of Evidence on Noninvasive Vagus Nerve Stimulation for Treatment of Migraine: Efficacy, Safety, and Implications

Mkaya Mwamburi, MD, PhD Andrew T. Tenaglia, BA Eric J. Leibler Peter S. Staats, MD, MBA

December 13th 2018

Noninvasive Vagus Nerve Stimulation in a Primary Care Setting: Effects on Quality of Life and Utilization Measures in Multimorbidity Patients With or Without Primary Headache

Iain Strickland, PhD, BSc Mkaya Mwamburi, MD, PhD Steven Davis BSc James C.R. Ward, MBBS Janet Day, MBChB Andrew T. Tenaglia, BA Eric J. Leibler Peter S. Staats, MD, MBA

December 13th 2018

Cost-effectiveness of Noninvasive Vagus Nerve Stimulation for Acute Treatment of Episodic Migraine and Role in Treatment Sequence Strategies

Mkaya Mwamburi, MD, PhD Andrew T. Tenaglia, BA Eric J. Leibler Peter S. Staats, MD, MBA

November 16th 2017

Review of Non-Invasive Vagus Nerve Stimulation (gammaCore): Efficacy, Safety, Potential Impact on Comorbidities, and Economic Burden for Episodic and Chronic Cluster Headache

Mkaya Mwamburi, MD, PhD (HEOR), MA (Econ) Eric J. Liebler, BA Andrew T. Tenaglia, BA

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Long-Term Follow-Up from CheckMate 9LA at ASCO 2024

Jason Porter, MD, an expert on lung cancer

Published: July 24th 2024 | Updated: July 27th 2024

Insights from the TROPION-Lung05 Trial at ASCO 2024

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School

Published: July 24th 2024 | Updated: July 27th 2024

Examining Trends, Future Directions in AI and Health Care

Aspirin tablets dissolving in water | Imaged credit: Victor Moussa - stock.adobe.com

Published: July 15th 2024 | Updated: July 27th 2024

No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD

Alfred L. Garfall, MD, an expert on multiple myeloma

Published: July 24th 2024 | Updated: July 27th 2024

Future Directions in the Management of Multiple Myeloma

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions